A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application

Condition:   Nasopharyngeal Neoplasms
Intervention:   Other: CAR-T cells
Sponsor:   The Second Hospital of Nanjing Medical University
Recruiting - verified November 2016

http://ift.tt/2gv76MT